Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jianhua Zang"'
Autor:
Lin Long, Yexi Zhang, Jianhua Zang, Peng Liu, Wei Liu, Cheng Sun, Dan Tian, Ping Li, Jin Tian, Jun Xiao
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveThis study aimed to investigate the impact of radiation therapy and radiation enteritis on intestinal flora, providing insights for treatment and prevention.MethodsFecal samples were collected from 16 patients undergoing pelvic radiotherapy
Externí odkaz:
https://doaj.org/article/36738f322be946a4b536e046797b49ce
Publikováno v:
The Clinical Respiratory Journal, Vol 18, Iss 5, Pp n/a-n/a (2024)
Abstract Objective This investigation aims to explore alterations in intestinal microecology and immune function among patients with advanced, unresectable lung adenocarcinoma undergoing different outcomes from immunotherapy. Methods A cohort of 30 p
Externí odkaz:
https://doaj.org/article/e63d0bdba0b249e7a15e7a96a7d40f45
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract This study aims to investigate the effects of hyperthermia on intestinal microecology, immune function, and progression-free survival of patients with advanced unresectable lung adenocarcinoma. A total of twenty patients with lung adenocarci
Externí odkaz:
https://doaj.org/article/f4221642939248fea9c955d3440f0f13
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Malignant pleural and peritoneal effusion are common clinical manifestations in advanced malignant tumors, associated with a poor prognosis. This article presents a case of advanced lung adenocarcinoma with ROS1 rearrangement, characterized by persis
Externí odkaz:
https://doaj.org/article/a0a5c14e136b4345837abd902d37f4af
Autor:
Ping Mo, Yanqi Xu, Xuegang Xu, Qian Li, Gang Sun, Minghua Wei, Kai Liu, Jianhua Zang, Chuanwu Jiang, Huijin Zheng, Fengyu Jia, Yan Wang
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 392:1477-1489
Ovarian cancer is a common human malignancy of the female reproductive system. However, chemotherapy has been proven to have limited effectiveness in a majority of patients. Resibufogenin (RB) is a major active ingredient in cinobufacini, which has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4aa3c51bdebb1e8ce6059fbb0005d242
https://doi.org/10.1007/s00210-019-01687-2
https://doi.org/10.1007/s00210-019-01687-2
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23bc5af9ccb7336a399e8c028494797c
https://pubmed.ncbi.nlm.nih.gov/32345450
https://pubmed.ncbi.nlm.nih.gov/32345450
Autor:
Qian, Li, Chuanwu, Jiang, Yan, Wang, Minghua, Wei, Huijin, Zheng, Yanqi, Xu, Xuegang, Xu, Fengyu, Jia, Kai, Liu, Gang, Sun, Jianhua, Zang, Ping, Mo
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 392(12)
Ovarian cancer is a common human malignancy of the female reproductive system. However, chemotherapy has been proven to have limited effectiveness in a majority of patients. Resibufogenin (RB) is a major active ingredient in cinobufacini, which has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::79553a08f52663c8c65739db7a0ea0a4
https://pubmed.ncbi.nlm.nih.gov/33242124
https://pubmed.ncbi.nlm.nih.gov/33242124
Autor:
Yanqi Xu, Xuegang Xu, Yan Wang, Fengyu Jia, Huijin Zheng, Gang Sun, Ping Mo, Jianhua Zang, Chuanwu Jiang, Kai Liu, Qian Li, Minghua Wei
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 394:575-575
Ovarian cancer is a common human malignancy of the female reproductive system. However, chemotherapy has been proven to have limited effectiveness in a majority of patients. Resibufogenin (RB) is a major active ingredient in cinobufacini, which has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7129e259e078b3e85131de8f413ce25
https://doi.org/10.1007/s00210-020-02016-8
https://doi.org/10.1007/s00210-020-02016-8